Table 1. Baseline of patient and treatment characteristics.

Characteristic	Value
Cases	14
Gender(cases/percent)
male	6/43
Female	8/57
Age(year)
Range	31–70
Media	53
Primary or metastases (cases/percent)
Primary	0
Metastases	14
Primary site (cases/percent)
Lung	11/78.6
Breast	1/7.1
Lymphoma	1/7.1
Gastric cancer	1/7.1
WBRT (cases/percent)
Yes	4/28.6
No	10/71.4
Dose(cGy)
Range	1400–4000
Media	2600
Dose line(%)
Range	50–82
Media	75
Fractions
Range	1–5
Media	2
BED (cGy)
Range	5980–9880
Media	7590
Frequency of bevacizumab
Range	3–10
Media	3